EVO
Evotec SE
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · DE
$1.60
−4.19%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 121.98x
- P/S forward
- 0.77x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.74x
- Price / sales
- 0.69x
- Price / cash flow
- -4.17x
Enterprise value
- Enterprise value
- $580.4M
- EV / sales
- 0.70x
- EV / EBITDA
- -5.90x
- EV / EBIT
- -3.93x
- Market cap
- $568.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026